ArticleThe Journal of investigative dermatology2022

Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris.

Napatra Tovanabutra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.